Has the Pot Stock Bubble Finally Burst?

It’s beginning to dawn on us that people invested in CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST), Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON), and Hexo Corp. (TSX:HEXO)(NYSE:HEXO) only because of the hype. The marijuana stock bubble has burst.

| More on:

Is the marijuana stock bubble about to burst or has it just done so?

A series of unfortunate events has bruised the image of the cannabis industry. There is too much drama coming from the perceived industry leader Canopy Growth down to the second-tier cannabis companies — and stock prices for weed have fallen sharply.

You can feel the dismay of investors. It wouldn’t surprise me if many of them regretted buying CannTrust (TSX:TRST)(NYSE:CTST), Cronos (TSX:CRON)(NASDAQ:CRON), and Hexo (TSX:HEXO)(NYSE:HEXO).

These cannabis companies are no longer on cloud nine.

The big scandal

CannTrust is in limbo after messing up big time. Health Canada discovered that the company sold cannabis produced from unlicensed cultivation rooms.

Now, Canadian securities regulators are conducting a deeper probe, and its inspectors might well unearth more serious violations and unsound practices.

A class action suit was filed against CannTrust by those who bought the stocks between November 14, 2018 and July 5, 2019. The complaint alleges that CannTrust issued false and misleading statements to investors. The suit also mentions that CannTrust was growing cannabis without regulatory approval.

In a recent statement, CannTrust said the company would likely miss the August 14 deadline to file its earnings report. That’s troubling for investors, as it’s only from the filing that they will know the company’s real status.

The outlook is bleak for future revenue and profitability. Furthermore, unless a serious buyer comes along, CannTrust is in danger of having its license revoked.

The overvaluation

With Cronos being cash-rich thanks to a $1.8 billion equity investment from tobacco giant Altria, it’s in a massive expansion mode. Last week, Cronos acquired Redwood, the owner of the popular brand Lord Jones. This brand is known for its hemp-derived CBD-infused skin care and other consumer products.

Redwood will receive $225 million in cash from Cronos and $75 million in newly issued stocks. The transaction has a minimal dilution of Cronos shareholders, and the company gains instant entry to the U.S. CBD market.

Cronos can scale in the CBD skin care market, which is predicted to be worth more than $6.3 billion by 2027. However, market analysts believe that Cronos is grossly overvalued and trading at a premium.

That’s the major problem with the stock. This negative sentiment could change, however, depending Cronos’ Q2 2019 earnings report.

Disappointing revenue

Hexo (TSX:HEXO)(NYSE:HEXO) is also in a predicament. There was some initial excitement when the joint venture with Molson Coors was announced. Still, some had their doubts about the acquisition of Newstrike Brands despite its potential for Hexo.

Through the partnership, the company expected to realize its vision of creating the best cannabis technology.

Investors’ interest soured, however, when Hexo’s third-quarter financial results showed only a pint-sized growth in revenue. While production doubled, the sales of recreational marijuana increased by only 8.75%, and medical sales dropped.

Overall, Hexo posted revenues of $13 million with a corresponding $1.9 million loss.

Since then, Hexo has underperformed after flying high earlier in the year. Hexo is presently holding talks with Fortune 500 companies. If the company can add a new partner by next year, things could change for the better. Until then, it’s wait-and-see for investors.

Final thoughts

Although the marijuana industry has seen many success stories, maybe the marijuana stock bubble has finally burst. Wait until stock prices hit the bottom before you invest in any of these companies.

Should you invest $1,000 in Enbridge right now?

Before you buy stock in Enbridge, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Enbridge wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »